↓ Skip to main content

SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.840783
Pubmed ID
Authors

Lorenzo Belluomini, Lorenzo Calvetti, Alessandro Inno, Giulia Pasello, Elisa Roca, Emanuela Vattemi, Antonello Veccia, Jessica Menis, Sara Pilotto

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 3 16%
Student > Ph. D. Student 1 5%
Other 1 5%
Researcher 1 5%
Student > Master 1 5%
Other 0 0%
Unknown 12 63%
Readers by discipline Count As %
Medicine and Dentistry 4 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Agricultural and Biological Sciences 1 5%
Unknown 12 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2022.
All research outputs
#9,012,357
of 26,550,749 outputs
Outputs from Frontiers in oncology
#3,611
of 23,253 outputs
Outputs of similar age
#171,352
of 455,082 outputs
Outputs of similar age from Frontiers in oncology
#231
of 1,558 outputs
Altmetric has tracked 26,550,749 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,253 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 1,558 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.